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A b s t r a c t  
Skin grafts transplanted from B 10.HTT donors onto (A.TL X B 10)F 1 recipients 
are rapidly rejected despite the fact that the B10.HTT and A.TL strains should be 
carrying the same H-2 chromosomes and that both the donor and the recipient 
contain the B10 genome. The rejection is accompanied by a production of cytotoxic 
antibodies against antigens controlled by the Ir region of the H-2 complex. These 
unexpected findings are interpreted as evidence for a third histocompatibility locus in 
the H~ complex, H-2I, located in the Ir region close to H-2K. The B 10.HTT and A.TL 
strains are postulated to differ at this hypothetical locus, and the difference between 
the two strains is explained as resulting from a crossing over between the H-2 tl and 
H-2 s chromosomes in the early history of the B10.HTT strain. The H-2 geno- 
types of the B10.HTT and A.TL strains are assumed to be H-2KsIrs/kSskH-2D d and 
H-2KsIrkSskH-2D d, respectively. Thus, the H-2 chromosomes of the two strains 
differ only in a portion of the Ir region, including the H-2I locus. The B 10.HTT(H-2 tt) 
and B10.S(7R)(H-2 th) strains differ in a relatively minor histocompatibility locus, 
possibly residing in the Tla region outside of the H-2 complex. 
Introduction 
The Ho2 system occupies a relatively small but extremely complex segment of  
mouse chromosome 17 (linkage group IX). This system controls antigens on 
various body tissues detectable by serological methods (Gorer 1938); rejection o f  
neoplastic (Gorer 1938) and normal (Amos et al. 1954) tissue transplants; graft-versus- 
host reaction (Simonsen and Jensen 1959); mixed lymphocyte reaction (Dutton 1966); 
production of  serum proteins (Shreffler and Owen 1963, Passmore and Shreffler 
1970); resistance to oncogenic viruses (Lilly et al. 1964); immune response to a 
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variety of antigens (McDevitt and Chinitz 1969); cell-mediated lymphocytotoxicity 
in vitro (Brunner et al. 1970); antigens of restricted tissue distribution (Hauptfeld et al. 
1973, David et al. 1973); cooperation between thymus and bone marrow-derived 
lymphocytes in antibody response (Katz et al. 1973), as well as other less well-defined 
functions. Genetically, the 1-1-2 complex consists of a large number of  loci that are 
presently grouped into four regions,H-2K, Ir, Ss, and H-2D. The role of the individual 
regions in the different H-2-associated functions is currently under investigation in 
several laboratories. We are engaged in a study of the contribution of the different 
H-2 regions to skin graft rejection (Klein and Shreffler 1972, Klein 1972 and this 
communication). During these studies we were confronted with a paradoxical situation 
in which mice carrying no known histocompatibility difference rapidly rejected each 
other's skin grafts. We explain this situation by the occurrence of a previously un- 
suspected genetic recombinational event within the H-2 complex and by the existence 
of a third, previously unidentified histocompatibility (H) locus in the H-2 complex. 
Mater ia ls  and M e t h o d s  
Mice. The following strains were used: B10.A(H-2a), BIO.D2(H-2d), B10.A(5R) 
(H-2i-zsg), B10.S(7R)(H-2th), B10.HTT(H-2tt; see Results and Discussion), 
A.AL(H-2al), A.TL(H-2t0, and A.TH(H-2th). The latter three strains were kindly 
provided to us by Dr. D. C. Shreffler, Department of Human Genetics, The University 
of Michigan Medical School; all other strains were bred in our own colonies at the 
University of Michigan. 
Skin Grafting. The skin grafting technique employed has been previously de- 
scribed (Klein and Bailey 1971). In one group, the grafts were taken from the ear, in 
all other groups we used skin from the tail. The grafts were placed in the dorsolateral 
region of the recipient's trunk. Bandages were removed between seven and nine days 
after grafting, and the grafts were inspected daily for the first four weeks and once a 
week thereafter. The recipient and the donor were always of the same sex, not 
younger than three months and not older than six months at the time of the grafting. 
Cytotoxic Test. The two-stage microcytotoxicity test was carried out as de- 
scribed by Amos and his coworkers (1969) with minor modifications. Briefly, two- 
fold serial dilutions of the antiserum were made in Hanks balanced salt solution 
(HBSS) containing 0.5% bovine serum albumin (BSA). The same medium was used to 
prepare the suspensions of lymph node lymphocytes (target cells). For testing, 2 #1. of 
the antiserum and 2 #l. of the target cells at a concentration of 3 X 106/ml were 
dispensed into plastic microtitre plates (Falcon Plastics, Los Angeles, Ca.) with a 
Hamilton syringe (Hamilton Co., Inc., Whittier, Ca.). After mixing, the plates were 
incubated for 20 rain at room temperature. The wells were then filled with HBSS and 
the plates incubated for another 10 min at room temperature. After flicking off the 
fluid, 2 #1. of complement were added to each well and the plates were incubated for 
30 min at 37~ The reaction was then arrested by cooling at 5~ for 5 rain, and the 
cells were fixed by addition of 2% formaldehyde in HBSS. Cells were transferred to 
hemocytometers and counted under a phase contrast microscope. Commercially 
available normal guinea pig serum diluted 1:8 was used as a source of complement 
(obtained from Grand Island Biological Co., New York, N.Y.). 
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Resul ts  
Backgroundlnformation. In previous studies (D~mant et al. 1971, Klein and 
Shreffler 1972)it was found that rejection of skin grafts across H-2 barriers is primarily 
the function of the peripheral H-2K and H-2D regions. A considerable portion of the 
central H-2 regions, particularly the Ss region and the region between Ss and H-2D, 
does not appear to be involved in skin graft rejection at all. However, the strain com- 
binations used in these studies did not allow any firm conclusions to be drawn about 
the involvement of the Ir region in skin graft rejection. For this reason, we began an 
analysis of H-2 recombinants differing in this region. Two such recombinants, H-2 TM 
and H-2tl, were produced by Stimpfling (Stimpfling and Reichert 1970) and Shreffler 
(Shreffler and David 1972), respectively. The postulated genetic origin of these re- 
combinants is shown in Fig. 1. The H-2 th chromosome was transferred by Stimpfling 
onto the C57BL/10 (abbreviated B 10) strain background (congenic line B 10.S(7R), 
abbreviated 7R), and by Shreffler onto the A strain background (congenic line A.TH). 
The H-2tl chromosome was first maintained in an outbred HTT stock, which was then 
used by P. Ivanyi and P. D6mant (personal communication) for the development of 
the B10.HTT congenic line. The original H-2 tl chromosome was also transferred by 
Shreffier onto the A strain background (congenic line A.TL). Before the establishment 
of the HTT stock, the H-2tl chromosome was maintained for two generations in a 
heterozygous state with H-2s. The A.TL line was established by backcrossing to 
A.CA(H-2f, cf. Meo et al. 1973b). 
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Fig. 1. Postulated Origin of Relevant H-2 Recombinant Chromosomes. 
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Skin Grafting Between 7R and BI O.HTT. Skin grafts exchanged between the 
B10.HTT and 7R strains show a peculiar histoincompatibility (Table 1). Some grafts 
are rejected relatively early after transplantation (between 17 and 30 days); others 
survive for more than 100 days. The proportion of the early rejected grafts is higher in 
females than in males and higher in the direction 7R~B10.HTT than in the opposite 
direction. A similar rejection pattern was described earlier for the histocompatibility 
locus associated with the Tla region (Boyse et al. 1972, Snell et al. 1971) located out- 
side of the H-2 complex near the H-2D end. We wondered, therefore, whether the 
B10.HTT and 7R strains might differ at this locus. The origin of the B10.HTT and 
7RH-2 chromosomes allows this theoretical possibility (see Fig. 1, and the Discussion). 
To test this hypothesis, we raised three types of F 1 hybrids-(B10.HTT • 5R)FI, 
(7R • B10.D2)F1, and (HTT • B10.A)FI- in which the presumed T/a difference is 
"covered" (complemented) by the H-2 chromosome of the second parent in the F 1 
hybrid. The 5R and B10.A strains carry the T/a region derived from the H-2a 
chromosome, as does the 7R strain, and both the B10.D2 and the B10.HTT strains 
carry the T/a region of H-2 a. In one combination, (7R-+(B10.HTT • 5R)F1), the 
grafts were still rejected in the same pattern as in the 7R-+B10.HTT combination; in 
the other two combinations, [B10.HTT-+ (7R • B10.D2)FI and 7R-+(B10.HTT • 
B10.A)F 1 ], the early rejection did not occur. Thus, this experiment did not provide 
unequivocal evidence for the involvement of the T/a region in the 7R-~B 10.HTT graft 
rejection. 
For comparison, grafts were exchanged between A.TH and A.TL mice (since we 
did not have enough of these mice, we used their F 1 hybrids with the B10 strain 
instead). We expected the same rejection pattern as in the 7R~B10.HTT combinations 
since the 7R and A.TH and the B10.HTT and A.TL strains were thought to carry the 
same H-2 chromosomes respectively. To our great surprise, the grafts were promptly 
rejected (Table 1). 
F 1 Tests Involving H-2 Chromosomes al, th, tl, tt, and s. To further explore the 
unexpectedly rapid rejections, we obtained a series of F 1 hybrids and grafted them 
with 71~, B10.HTT and A.TL skin (Table 2). 
The (A.AL • B10.S)F 1 hybrids showed no early rejections of  either A.TL or 
B 10.HTT grafts, indicating that whatever the difference between the H-2 chromosomes 
of the two donor strains, it was not an antigen that these F 1 hybrids lacked. Further- 
more, since the F 1 recipients carried the H-2 chromosomes from which the A.TL and 
B10.HTT recombinant chromosomes were originally derived, the results also suggested 
that no other H-2 chromosome beside al or s could have contributed the antigen in 
which the two donor strains differed. 
The (A.TH • B10)F 1 hybrids accepted grafts from both B10.HTT and 7R 
donors (all except one survived for more than 100 days). In sharp contrast, the 
(A.TL X B10)F 1 hybrids promptly rejected all grafts from these two donor strains. 
These results clearly indicate that the H-2 chromosomes of the A.TL and B10.HTT 
strains, originally believed to be identical, are actually different and that this difference 
can cause rapid skin graft rejection. Due to the nature of  the Fx test, it is unlikely that 
the early rejections were due to the difference in the genetic backgrounds of the 
strains involved. The same difference was apparently also responsible for the rejection 
of 7R grafts by the (A.TL X B10)F 1 hybrids but was not responsible for the rejection 




















































































































































































































































































































































































































































































































































































































































































































































































































Ir Association Histoincompatibility 51 
SerologicalAnalysis. Sixteen days after grafting of the (A.TL X B10)F 1 
hybrids with B10.HTT skin, the recipients were bled and their sera tested in the 
microcytotoxic assay against the lymph node cells of the donor. The tests revealed 
the presence of antibodies reacting with some 45 to 65% of the B10.HTT lymph node 
cells (Fig. 2). The antisera also reacted with lymphocytes from the spleen but did not 
react with thymocytes. A positive reaction with 7R, B10.S, and A.TH lymphocytes 
indicated that the antibodies were directed against antigens shared by the B10.HTT, 
7R, A.TH, and B10.S strains but absent in the A.TL strain. Testing of the antiserum 
against a series of H-2 recombinants (results to be published elsewhere) suggested that 
the antigens detected by this antiserum are controlled by the Ir region of the H-2 
complex. In all other characteristics, the (A.TL X B10)F 1 anti-B10.HTT serum re- 
sembles other sera obtained in our laboratory and several other laboratories by 
immunization across Ir region differences. 
Discussion 
It appears that there are two types of histocompatibility differences involved in 
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Fig. 2. Reactions in the Microcytotoxicity Test of Antiserum (A.TL X B 10)F 1 
Anti-B10.HTT with Lymph Node Cells of 7R ( ~ - - - - - - ~ ) ,  B10.HTT (9 9 
(B10 X A.TL)F 1 ( ;  : ) ,  and with Thymocytes of 7R (Ib------..4) and B10.HTT 
( o - - - - o ) .  
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all grafts across this barrier are rejected during the first three weeks after trans- 
plantation, by both males and females. The other difference is relatively minor, 
causing irregular rejections, with some grafts (particularly in females) rejected early, 
and others (particularly in males) rejected late or not at all. 
The strong histoincompatibility is observed when skin grafts are transplanted 
between the A.TH and A.TL strains, or between the A.TL and B10.HTT strains. The 
H locus responsible for the strong rejection appears to be linked to the 11-2 complex. 
[The A.TL and A.TH strains have the same genetic background; in the B10.HTT-~ 
(A.TL X B 10)F 1 combination the background of the donor is contributed by the B 10 
parent of the F 1 recipient. Thus, the rejections are unlikely to be due to a difference 
in genes segregating independently of 1-1-2. ] 
At the outset of the experiments we presumed that the 11-2 chromosomes of the 
B10.HTT and A.TL strains were the same, since both strains were derived from the 
same recombinant mouse. However, the fact that B IO.HTT and A.TL strains reject 
each other's skin grafts and that this rejection is not due to background differences 
indicates that the H-2 chromosomes are not  the same. After separation of the strains, 
a genetic change resulting in a strong H locus difference must have occurred in one of 
them. We suggest that the change represented additional crossing over in the HTT 
stock, while it was still heterozygous for the H-2fl and H-2s chromosomes. We assume 
that the postulated crossing over between the tl  and s chromosomes occurred in the 
Ir region of the 11-2 complex in such a way that the new recombinant chromosome 
received the H-2K region and part of the Ir region from the 1-1-2 s chromosome, and the 
rest of the H-2 complex from the H-2 tl chromosome (Fig. 1). The genotype of the 
new chromosome can, therefore, be written as H-2Kslrs/kSskH-2Dd. It should differ 
from the genotype of the H-2tl chromosome (H-2KslrkSskDd) only in a portion of 
the Ir region. The tl and recombinant chromosomes should not differ in the H-2K, Ss, 
and H-2D regions. This assumption has been confirmed by testing the B10.HTT and 
the A.TL mice with monospecific anti-H-2 sera and with anti-Ss and anti-Slp sera (J. 
Klein, unpublished data). 
The assumption that BIO.HTT and A.TL strains differ in the Ir region is supported 
by the serological analysis of the (A.TL • B10)F 1 anti-B10.HTT serum, which reacts 
as if directed against antigens controlled by the region between H-2K and Ss (V. 
Hauptfeld and J. Klein, in preparation). Strong support for this conclusion comes also 
from Ir-1 typing of the BI0.HTT strain. According to H. O. McDevitt (personal 
communication), the B 10.HTT mice, like those of the B 10.S strain, are low responders 
to (T,G)-A--L, (H,G)-A--L and (Phe,G)-A--L antigens. The A.TL strain, on the other 
hand, is a low responder to (T,G)-A--L and a high responder to (H,G)-A--L and 
(Phe,G)-A--L. 
All this confirms the hypothesis that the H-2 chromosome of the BIO.HTT 
strain arose by crossing over between H-2fl and H-2s as shown in Fig. 1. Meo and his 
coworkers (1973b) recently reached the same conclusion on the basis of their observa- 
tion that A.TH and B10.HTT stimulate each other strongly in MLR. These authors 
have assigned the symbol H-2 tt to the new 11-2 chromosome of the B10.HTT strain. 
We have adopted this symbol. 
Alternatively, the H-2 tt chromosome may have originated by a mutation in the 
Ir region. However, this interpretation would require that the mutation occurred, by 
chance, in the direction Irk-firs. The probability of this happening is extremely small, 
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particularly if one assumes that the change involved more than one gene. 
No matter what the origin of the H-2 tt chromosome, it is clear that its difference 
from the H-2tl chromosome exerts a relatively strong effect on skin graft rejection 
and that this difference is located in the Ir region. The postulated H gene(s), which we 
designate H-2I, is probably located in close proximity to the H-2K region within the 
H-2 complex. 
The contention that the H-2I gene is located close to the H-2K region is supported 
by the finding that B10.A(2R) and B10.A(4R) strains, which differ only in the portion 
of the Ir region proximal to Ss (Lieberman et al. 1972), are histocompatible 
(Stimpfling and Reichert 1970, Livnat et al. 1973). In another pair of Ir congenic 
lines, B10.T(6R) and B10.AQR, rapid rejection of skin grafts is known to occur in at 
least one direction [B10.T(6R)-+B10.AQR (cf. Livnat et al. 1973]. This rejection can 
also be attributed to the H locus in the vicinity of Ir-1. 
The relationship of the H-2I locus to the Ir-1 gene and to the gene(s) responsible 
for Ir region-associated MLR (Bach et al. 1972, Meo et al. 1973a) and GVHR (Klein 
and Park 1973) is not clear. However, since there is enough room in the Ir region for 
some 500 genes, mapping of two genes in this same chromosomal segment by no 
means indicates identity of the genes. 
On the other hand, the possibility that the H-2I locus is identical with the 
recently discovered IrR-1 (Hauptfeld et al. 1973) or Lna (David et al. 1973) loci must 
be seriously considered. The antibodies produced by immunization of the (A.TL • 
B10)F 1 recipients with the B10.HTT tissue seem to be directed against the IrR-1 (Lna) 
antigens. The fact that such antibodies accompany skin graft rejection suggest that 
the IrR-1 (Lna) antigens are also present on epithelial cells. However, it is also possible 
that the antibodies are produced against passenger lymphocytes of the skin graft 
(Steinmuller and Hart 1971) rather than against the skin itself. Experiments are in 
progress to distinguish between these two possibilities. 
The existence of the H-2I gene could explain why skin grafts exchanged between 
congenic lines differing in the H-2K subdivision (H-2K+Ir) are rejected more rapidly 
than those transplanted across the H-2D subdivision (Klein t972, McKe'nzie and Snell 
1973): The prompt rejection could be due to a cumulative effect of H-2K and H-2I in 
the H-2K subdivision. 
The existence of a third histocompatibility region in the 11-2 complex could also 
explain the asymmetry in the formation of hemizygous variants from H-2 heterozygous 
tumors (for discussion see Klein 1972). 
The minor histoincompatibility observed when grafts are exchanged between the 
B10.HTT and 7R strains could be due to either a residual background difference between 
these two strains (i.e., to a minor H gene unlinked to H-2) or to an H gene in the 1-1-2 
chromosome. In the latter case, the H gene could be located either in the Ss region or 
anywhere to the right of Ss (between Ss and H-2D, in H-2D, or outside of H-2D). If 
H-2-associated, the minor barrier could result from the difference in origin of the D 
subdivisions in the th and tt chromosomes. The th chromosome is derived from an 
a/s heterozygote, and the a chromosome, in turn, is believed to have originated from 
the d and k chromosomes. However, since it is not known when the a recombination 
took place and which strains it involved, it is conceivable that the d chromosome that 
gave rise to a was not identical with the currently known d. (This is indicated by the d* 
symbol in Fig. 1). Since the D subdivision of the tt chromosome is ultimately derived 
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(through tl and al) from the d (and not from the hypothetical d*) chromosome, one 
may speculate that the different origin of the d and d* chromosomes is responsible 
for the observed histoincompatibility. The two chromosomes may differ, for example, 
in the T/a region, as we have indicated. Unfortunately, in an attempt to prove this, the 
results were inconclusive. In one strain combination, complementation with Tla had 
no effect on the rejection, whereas in the other two combinations it seemed to have 
eliminated the incompatibility. Perhaps in the former case the rejections were due to 
residual background differences. 
Finally, it is interesting to note that if the H-2tt chromosome indeed arose by 
crossing over, it represents another case in which this relatively rare event (the overall 
frequency of intra-H-2 crossing over is 0.3%) occurred twice in rapid succession; 
other instances are described (Shreffler and David 1972). It appears that occurrence 
of one crossing over increases the chances of additional crossing over in the same 
chromosomal region. Such chromosomal instability could be due to the presence of a 
high number of duplicated genes in the H-2 complex. 
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